{"transactions":[{"id":717645,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-07-02T20:05:16.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":168618,"source":{"system":"sec-edgar","filing":"0001104659-26-080309","document":"tm2619538-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465926080309/tm2619538-1_4seq1.xml","form_type":"4"}},{"id":725389,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-06-26T20:18:52.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":118618,"source":{"system":"sec-edgar","filing":"0001104659-26-078282","document":"tm2619089-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465926078282/tm2619089-4_4seq1.xml","form_type":"4"}},{"id":957125,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2025-12-30T21:17:34.000Z","date":"2025-12-30","kind":"sale","planned":false,"acquired":false,"shares":247,"price":0.962,"value":237.614,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a private sale of 247 shares of common stock to another member of the board of directors of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":145,"source":{"system":"sec-edgar","filing":"0001104659-25-125233","document":"tm2534509-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465925125233/tm2534509-3_4seq1.xml","form_type":"4"}},{"id":1072128,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-08-07T21:14:23.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 5, 2025, the reporting person was granted 20,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029 and 6,666 shares on August 5, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":108618,"source":{"system":"sec-edgar","filing":"0001104659-25-075260","document":"tm2522819-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465925075260/tm2522819-1_4seq1.xml","form_type":"4"}},{"id":1091211,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-07-08T01:46:22.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":7173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2025, the reporting person was granted 7,173 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in full on June 25, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":88618,"source":{"system":"sec-edgar","filing":"0001104659-25-066236","document":"tm2520050-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465925066236/tm2520050-1_4seq1.xml","form_type":"4"}},{"id":1129109,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2025-05-30T15:17:24.000Z","date":"2025-05-30","kind":"other","planned":false,"acquired":false,"shares":147007,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of in connection with an offer made pursuant to the Agreement and Plan of Merger, dated as of March 9, 2025 and as amended on April 14, 2025 (the \"Merger Agreement\"), in exchange for $4.10 per share, net to the holder in cash, plus one contractual contingent value right (\"CVR\") per share. Each CVR represents the right to receive a payment ranging from $0.20 to $0.70 pursuant to certain milestone payments as defined in the Merger Agreement relating to the regulatory approval for cosibelimab in the European Union. The CVR milestone must be achieved within thirty-six (36) months after the date on which a marketing authorization application or equivalent application for cosibelimab receives a positive validation outcome by the European Medicines Agency."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-054688","document":"tm2516581-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465925054688/tm2516581-4_4seq1.xml","form_type":"4"}},{"id":1129108,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2025-05-30T15:17:24.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":12195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskotitz's continued service on the board."}],"balance_after":147007,"source":{"system":"sec-edgar","filing":"0001104659-25-054688","document":"tm2516581-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465925054688/tm2516581-4_4seq1.xml","form_type":"4"}},{"id":1328422,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2024-12-18T02:30:08.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":17638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on December 13, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":134812,"source":{"system":"sec-edgar","filing":"0001104659-24-129522","document":"tm2431396-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465924129522/tm2431396-1_4seq1.xml","form_type":"4"}},{"id":1344760,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2024-12-03T21:30:17.000Z","date":"2024-12-02","kind":"sale","planned":false,"acquired":false,"shares":23,"price":2,"value":46.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective April 26, 2024, the Issuer effected a one-for-seventy-five reverse stock split of its common stock (the \"Reverse Stock Split\") and the amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":97,"source":{"system":"sec-edgar","filing":"0001104659-24-125093","document":"tm2429982-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465924125093/tm2429982-1_4seq1.xml","form_type":"4"}},{"id":1399420,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2024-09-25T20:57:49.000Z","date":"2024-09-23","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2025; (ii) one-third of the shares subject to the option vest on January 1, 2026; and (iii) one-third of the shares subject to the option vest on January 1, 2027."}],"balance_after":30000,"derivative":{"exercise_price":2.46,"expiration_date":"2034-09-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-24-102839","document":"tm2424771-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465924102839/tm2424771-6_4seq1.xml","form_type":"4"}},{"id":1456892,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-07-10T20:45:23.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":9728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 8, 2024, the reporting person was granted 9,728 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 8, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":81445,"source":{"system":"sec-edgar","filing":"0001104659-24-078972","document":"tm2419199-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465924078972/tm2419199-3_4seq1.xml","form_type":"4"}},{"id":1514061,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2024-05-16T23:31:24.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The 50,000 shares of restricted Common Stock will vest according to the following schedule, subject to Mr. Herskowitz's continued service on the board on each date: one third on May 14, 2027, one third on May 14, 2028, and one third on May 14, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskowitz's continued service on the board."}],"balance_after":117174,"source":{"system":"sec-edgar","filing":"0001104659-24-062663","document":"tm2414703-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465924062663/tm2414703-2_4seq1.xml","form_type":"4"}},{"id":1514060,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2024-05-16T23:31:24.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":32051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 32,051 shares of restricted Common Stock will vest on May 14, 2027, subject to Mr. Herskowitz's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskowitz's continued service on the board."}],"balance_after":67174,"source":{"system":"sec-edgar","filing":"0001104659-24-062663","document":"tm2414703-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465924062663/tm2414703-2_4seq1.xml","form_type":"4"}},{"id":1823444,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-07-25T20:07:21.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":27472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2023, the reporting person was granted 27,472 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 61,717 restricted stock units, 27,472 of which will vest in full on July 21, 2024 as set forth in footnote 1, and 10,000 units of which will vest on July 1, 2024."}],"balance_after":71717,"source":{"system":"sec-edgar","filing":"0001104659-23-083836","document":"tm2321950-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465923083836/tm2321950-1_4seq1.xml","form_type":"4"}},{"id":1832821,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-07-07T20:06:18.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":7246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 7,246 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 5, 2023. The shares will vest on July 5, 2026, subject to the Reporting Person's continued service on the Issuer's board on such date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":19703,"source":{"system":"sec-edgar","filing":"0001104659-23-079111","document":"tm2320790-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465923079111/tm2320790-2_4seq1.xml","form_type":"4"}},{"id":1835722,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2023-07-05T20:07:28.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2024; (ii) one-third of the shares subject to the option vest on January 1, 2025; and (iii) one-third of the shares subject to the option vest on January 1, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":100000,"derivative":{"exercise_price":1.14,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-23-078088","document":"tm2320488d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465923078088/tm2320488d1_4seq1.xml","form_type":"4"}},{"id":1854125,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-06-16T00:00:43.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":17483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 17,483 shares of restricted Common Stock will vest on June 13, 2026, subject to Mr. Herskowitz's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskowitz's continued service on the board."}],"balance_after":35123,"source":{"system":"sec-edgar","filing":"0001104659-23-071758","document":"tm2318836-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465923071758/tm2318836-3_4seq1.xml","form_type":"4"}},{"id":1932169,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-04-03T20:50:19.000Z","date":"2022-07-29","kind":"grant","planned":false,"acquired":true,"shares":71664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 71,664 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 29, 2022. The shares will vest on June 17, 2025, subject to the Reporting Person's continued service on the Issuer's board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":186861,"source":{"system":"sec-edgar","filing":"0001104659-23-040929","document":"tm2311237-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465923040929/tm2311237-4_4seq1.xml","form_type":"4"}},{"id":2202752,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-25T13:36:51.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":14245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 34,245 restricted stock units, 14,245 of which will vest over various time periods as set forth in footnote 1, and 20,000 of which will vest in increments as follows: (1) 10,000 units on July 1, 2023, and (2) 10,000 units on July 1, 2024."}],"balance_after":44245,"source":{"system":"sec-edgar","filing":"0001104659-22-082288","document":"tm2221508-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465922082288/tm2221508-4_4seq1.xml","form_type":"4"}},{"id":2221908,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-06-25T01:54:37.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":47619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 47,619 shares of restricted Common Stock will vest on June 16, 2025, subject to Mr. Herskowitz's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskowitz's continued service on the board."}],"balance_after":176401,"source":{"system":"sec-edgar","filing":"0001104659-22-074467","document":"tm229209-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465922074467/tm229209-1_4seq1.xml","form_type":"4"}},{"id":2307835,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-04-04T20:51:39.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 30,000 restricted stock units relating to this grant will vest in three increments as follows: (1) 10,000 units on July 1, 2022, (2) 10,000 units on July 1, 2023, and (3) 10,000 units on July 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods as set forth in footnote 1."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-22-042276","document":"tm2211324-8_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465922042276/tm2211324-8_4.xml","form_type":"4"}},{"id":2462285,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T21:26:00.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This RSA vests on March 15, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 85,668 shares of restricted stock."}],"balance_after":183744,"source":{"system":"sec-edgar","filing":"0001104659-21-152198","document":"tm2135922-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465921152198/tm2135922-2_4seq1.xml","form_type":"4"}},{"id":2462284,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T21:26:00.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":49020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock award (RSA) vests on December 17, 2024, three years after the date granted."}],"balance_after":163744,"source":{"system":"sec-edgar","filing":"0001104659-21-152198","document":"tm2135922-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465921152198/tm2135922-2_4seq1.xml","form_type":"4"}},{"id":2637970,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-07-08T20:31:18.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":13774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 13,774 restricted shares pursuant to the Issuer's 2016 Incentive Plan on June 28, 2021. The shares will vest on June 17, 2024, subject to the Reporting Person's continued service on the Issuer's board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":115197,"source":{"system":"sec-edgar","filing":"0001104659-21-090240","document":"tm2121675-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465921090240/tm2121675-2_4seq1.xml","form_type":"4"}},{"id":2671687,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-11T23:59:48.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":16502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 16,502 shares of restricted Common Stock will vest on June 10, 2024, subject to Mr. Herskowitz's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskowitz's continued service on the board."}],"balance_after":128782,"source":{"system":"sec-edgar","filing":"0001104659-21-080361","document":"tm2119513-2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465921080361/tm2119513-2_4.xml","form_type":"4"}},{"id":2722801,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-07T12:02:09.000Z","date":"2021-05-06","kind":"purchase","acquired":true,"shares":2500,"price":3.99,"value":9975.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 67,997 shares of restricted stock."}],"balance_after":134724,"source":{"system":"sec-edgar","filing":"0001104659-21-062774","document":"tm2115514d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465921062774/tm2115514d1_4.xml","form_type":"4"}},{"id":3052122,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T20:32:32.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":16611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"101,423 shares are restricted Common Stock which vest over various time periods."}],"balance_after":101423,"source":{"system":"sec-edgar","filing":"0001104659-20-096924","document":"tm2028955d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465920096924/tm2028955d2_4.xml","form_type":"4"}},{"id":3108752,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T21:09:09.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common Stock vests upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 84,663 shares of restricted stock."}],"balance_after":132224,"source":{"system":"sec-edgar","filing":"0001104659-20-073824","document":"tm2022744d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465920073824/tm2022744d1_form4.xml","form_type":"4"}},{"id":3116110,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-06-09T20:32:35.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":24390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 24,390 shares of restricted Common Stock will vest on June 5, 2023, subject to Mr. Herskowitz's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskowitz's continued service on the board."}],"balance_after":112280,"source":{"system":"sec-edgar","filing":"0001104659-20-071411","document":"tm2022118d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465920071411/tm2022118d3_4.xml","form_type":"4"}},{"id":3237820,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T13:10:59.000Z","date":"2020-02-27","kind":"purchase","acquired":true,"shares":2400,"price":8.2,"value":19680.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 74,663 shares of restricted stock."}],"balance_after":122224,"source":{"system":"sec-edgar","filing":"0001104659-20-027510","document":"tm2011386d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465920027510/tm2011386d1_4.xml","form_type":"4"}},{"id":3237819,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T13:10:59.000Z","date":"2020-02-26","kind":"purchase","acquired":true,"shares":161,"price":8.73,"value":1405.53,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 74,663 shares of restricted stock."}],"balance_after":119824,"source":{"system":"sec-edgar","filing":"0001104659-20-027510","document":"tm2011386d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465920027510/tm2011386d1_4.xml","form_type":"4"}},{"id":3248915,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-25T21:53:45.000Z","date":"2020-02-25","kind":"purchase","acquired":true,"shares":10000,"price":9.31,"value":93100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 74,663 shares of restricted stock."}],"balance_after":119663,"source":{"system":"sec-edgar","filing":"0001104659-20-024813","document":"tm2010943d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465920024813/tm2010943d1_4.xml","form_type":"4"}},{"id":3307659,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-17T22:44:43.000Z","date":"2019-08-28","kind":"grant","acquired":true,"shares":13812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"83,812 shares are restricted Common Stock which vest over various time periods."}],"balance_after":84812,"source":{"system":"sec-edgar","filing":"0001104659-20-005211","document":"tm203350d4_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000110465920005211/tm203350d4_form4.xml","form_type":"4"}},{"id":3427302,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-28T20:17:06.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common Stock vests upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen."}],"balance_after":109663,"source":{"system":"sec-edgar","filing":"0001144204-19-042093","document":"tv528433_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419042093/tv528433_form4.xml","form_type":"4"}},{"id":3483976,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-19T20:54:07.000Z","date":"2019-06-18","kind":"purchase","acquired":true,"shares":2000,"price":5.83,"value":11660.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 64,663 shares of restricted stock."}],"balance_after":99663,"source":{"system":"sec-edgar","filing":"0001144204-19-031499","document":"tv523735_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419031499/tv523735_4.xml","form_type":"4"}},{"id":3483975,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-19T20:54:07.000Z","date":"2019-06-17","kind":"purchase","acquired":true,"shares":3000,"price":5.88,"value":17640.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 64,663 shares of restricted stock."}],"balance_after":97663,"source":{"system":"sec-edgar","filing":"0001144204-19-031499","document":"tv523735_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419031499/tv523735_4.xml","form_type":"4"}},{"id":3489386,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2019-06-14T20:47:11.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":11442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 11,442 shares of restricted Common Stock will vest on June 13, 2022, subject to Mr. Herskowitz's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Herskowitz's continued service on the board."}],"balance_after":87890,"source":{"system":"sec-edgar","filing":"0001144204-19-031018","document":"tv523631_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419031018/tv523631_4.xml","form_type":"4"}},{"id":3555778,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-15T20:33:39.000Z","date":"2019-04-15","kind":"purchase","acquired":true,"shares":1000,"price":4.52,"value":4520.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 64,663 shares of restricted stock."}],"balance_after":94663,"source":{"system":"sec-edgar","filing":"0001144204-19-019691","document":"tv518915_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419019691/tv518915_4.xml","form_type":"4"}},{"id":3573923,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-29T20:33:34.000Z","date":"2019-03-29","kind":"purchase","acquired":true,"shares":1400,"price":5.11,"value":7154.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 64,663 shares of restricted stock."}],"balance_after":93663,"source":{"system":"sec-edgar","filing":"0001144204-19-017010","document":"tv517581_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419017010/tv517581_4.xml","form_type":"4"}},{"id":3573922,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-29T20:33:34.000Z","date":"2019-03-28","kind":"purchase","acquired":true,"shares":600,"price":5.11,"value":3066.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 64,663 shares of restricted stock."}],"balance_after":92263,"source":{"system":"sec-edgar","filing":"0001144204-19-017010","document":"tv517581_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419017010/tv517581_4.xml","form_type":"4"}},{"id":3609381,"issuer":{"id":142239,"kind":"organization","name":"NATIONAL HOLDINGS CORP","symbol":"NHLD"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-03-06T19:47:58.000Z","date":"2019-02-13","kind":"exercise","acquired":false,"shares":7098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On February 12, 2018, the reporting person was granted 10,593 restricted stock units. The Company's Board of Directors approved accelerated vesting of the remaining shares on February 13, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On February 12, 2018, the reporting person was granted 10,593 restricted stock units. The Company's Board of Directors approved accelerated vesting of the remaining shares on February 13, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7098},"source":{"system":"sec-edgar","filing":"0001437749-19-004251","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1023844/000143774919004251/rdgdoc.xml","form_type":"4"}},{"id":3609380,"issuer":{"id":142239,"kind":"organization","name":"NATIONAL HOLDINGS CORP","symbol":"NHLD"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-03-06T19:47:58.000Z","date":"2019-02-13","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On February 12, 2018, the reporting person was granted 50,000 restricted stock units. The Company's Board of Directors approved accelerated vesting of the remaining shares on February 13, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On February 12, 2018, the reporting person was granted 50,000 restricted stock units. The Company's Board of Directors approved accelerated vesting of the remaining shares on February 13, 2019."}],"balance_after":7098,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-19-004251","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1023844/000143774919004251/rdgdoc.xml","form_type":"4"}},{"id":3609379,"issuer":{"id":142239,"kind":"organization","name":"NATIONAL HOLDINGS CORP","symbol":"NHLD"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-03-06T19:47:58.000Z","date":"2019-02-12","kind":"exercise","acquired":false,"shares":3495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On February 12, 2018, the reporting person was granted 10,593 restricted stock units. These stock units vest in three equal annual installments beginning February 12, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On February 12, 2018, the reporting person was granted 10,593 restricted stock units. These stock units vest in three equal annual installments beginning February 12, 2019."}],"balance_after":32098,"derivative":{"underlying":"Common Stock","underlying_shares":3495},"source":{"system":"sec-edgar","filing":"0001437749-19-004251","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1023844/000143774919004251/rdgdoc.xml","form_type":"4"}},{"id":3609378,"issuer":{"id":142239,"kind":"organization","name":"NATIONAL HOLDINGS CORP","symbol":"NHLD"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-03-06T19:47:58.000Z","date":"2019-02-12","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 12, 2018, the reporting person was granted 50,000 restricted stock units. These stock units vest in two equal annual installments beginning February 12, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On February 12, 2018, the reporting person was granted 50,000 restricted stock units. These stock units vest in two equal annual installments beginning February 12, 2019."}],"balance_after":35593,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-19-004251","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1023844/000143774919004251/rdgdoc.xml","form_type":"4"}},{"id":3609377,"issuer":{"id":142239,"kind":"organization","name":"NATIONAL HOLDINGS CORP","symbol":"NHLD"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-03-06T19:47:58.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":10593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in three equal annual installments beginning February 12, 2019. Vested shares will be delivered to the reporting person annually in accordance to the vesting delivery schedule. The Company's Board of Directors approved accelerated vesting of the remaining shares on February 13, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in three equal annual installments beginning February 12, 2019. Vested shares will be delivered to the reporting person annually in accordance to the vesting delivery schedule. The Company's Board of Directors approved accelerated vesting of the remaining shares on February 13, 2019."}],"balance_after":60593,"derivative":{"underlying":"Common Stock","underlying_shares":10593},"source":{"system":"sec-edgar","filing":"0001437749-19-004251","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1023844/000143774919004251/rdgdoc.xml","form_type":"4"}},{"id":3609376,"issuer":{"id":142239,"kind":"organization","name":"NATIONAL HOLDINGS CORP","symbol":"NHLD"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-03-06T19:47:58.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in two equal annual installments beginning February 12, 2019. Vested shares will be delivered to the reporting person annually in accordance to the vesting delivery schedule. The Company's Board of Directors approved accelerated vesting of the remaining shares on February 13, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in two equal annual installments beginning February 12, 2019. Vested shares will be delivered to the reporting person annually in accordance to the vesting delivery schedule. The Company's Board of Directors approved accelerated vesting of the remaining shares on February 13, 2019."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-19-004251","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1023844/000143774919004251/rdgdoc.xml","form_type":"4"}},{"id":3609375,"issuer":{"id":142239,"kind":"organization","name":"NATIONAL HOLDINGS CORP","symbol":"NHLD"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-06T19:47:58.000Z","date":"2019-02-13","kind":"exercise","acquired":true,"shares":7098,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converted into one share of National Holdings Corporation (the \"Company\") common stock."}],"balance_after":60593,"source":{"system":"sec-edgar","filing":"0001437749-19-004251","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023844/000143774919004251/rdgdoc.xml","form_type":"4"}},{"id":3609374,"issuer":{"id":142239,"kind":"organization","name":"NATIONAL HOLDINGS CORP","symbol":"NHLD"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-06T19:47:58.000Z","date":"2019-02-13","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converted into one share of National Holdings Corporation (the \"Company\") common stock."}],"balance_after":53495,"source":{"system":"sec-edgar","filing":"0001437749-19-004251","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023844/000143774919004251/rdgdoc.xml","form_type":"4"}},{"id":3609373,"issuer":{"id":142239,"kind":"organization","name":"NATIONAL HOLDINGS CORP","symbol":"NHLD"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-06T19:47:58.000Z","date":"2019-02-12","kind":"exercise","acquired":true,"shares":3495,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converted into one share of National Holdings Corporation (the \"Company\") common stock."}],"balance_after":28495,"source":{"system":"sec-edgar","filing":"0001437749-19-004251","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023844/000143774919004251/rdgdoc.xml","form_type":"4"}},{"id":3609372,"issuer":{"id":142239,"kind":"organization","name":"NATIONAL HOLDINGS CORP","symbol":"NHLD"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-03-06T19:47:58.000Z","date":"2019-02-12","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converted into one share of National Holdings Corporation (the \"Company\") common stock."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001437749-19-004251","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023844/000143774919004251/rdgdoc.xml","form_type":"4"}},{"id":3635557,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-25T21:13:01.000Z","date":"2019-02-25","kind":"purchase","acquired":true,"shares":5000,"price":5.46,"value":27300.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 64,663 shares of restricted stock."}],"balance_after":91663,"source":{"system":"sec-edgar","filing":"0001144204-19-009857","document":"tv512626_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419009857/tv512626_4.xml","form_type":"4"}},{"id":3672143,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-06T21:31:02.000Z","date":"2019-02-05","kind":"purchase","acquired":true,"shares":1850,"price":5.77,"value":10674.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,663 shares of restricted stock."}],"balance_after":86663,"source":{"system":"sec-edgar","filing":"0001144204-19-005339","document":"tv512626_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419005339/tv512626_form4.xml","form_type":"4"}},{"id":3672142,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-06T21:31:02.000Z","date":"2019-02-04","kind":"purchase","acquired":true,"shares":7000,"price":5.91,"value":41370.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-day open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on February 4, 2019 was $5.90 to $5.97. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,663 shares of restricted stock."}],"balance_after":84813,"source":{"system":"sec-edgar","filing":"0001144204-19-005339","document":"tv512626_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419005339/tv512626_form4.xml","form_type":"4"}},{"id":3679618,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-01T17:48:08.000Z","date":"2019-01-30","kind":"purchase","acquired":true,"shares":650,"price":5.91,"value":3841.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 64,663 shares of restricted stock."}],"balance_after":77813,"source":{"system":"sec-edgar","filing":"0001144204-19-004355","document":"tv512263_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419004355/tv512263_form4.xml","form_type":"4"}},{"id":3682537,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-30T21:18:32.000Z","date":"2019-01-29","kind":"purchase","acquired":true,"shares":8553,"price":5.91,"value":50548.23,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-day open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on January 28, 2019 was $5.82 to $5.89 and the range of prices for the purchase transactions on January 29, 2019 was $5.86 to $5.99. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,663 shares of restricted stock."}],"balance_after":77163,"source":{"system":"sec-edgar","filing":"0001144204-19-003774","document":"tv512042_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419003774/tv512042_form4.xml","form_type":"4"}},{"id":3682536,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-30T21:18:32.000Z","date":"2019-01-28","kind":"purchase","acquired":true,"shares":1447,"price":5.84,"value":8450.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-day open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on January 28, 2019 was $5.82 to $5.89 and the range of prices for the purchase transactions on January 29, 2019 was $5.86 to $5.99. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,663 shares of restricted stock."}],"balance_after":68610,"source":{"system":"sec-edgar","filing":"0001144204-19-003774","document":"tv512042_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420419003774/tv512042_form4.xml","form_type":"4"}},{"id":3739312,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-12-07T21:44:10.000Z","date":"2018-11-23","kind":"purchase","acquired":true,"shares":1000,"price":3.96,"value":3960.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"70,000 shares are restricted Common Stock which vest over various time periods."}],"balance_after":71000,"source":{"system":"sec-edgar","filing":"0001144204-18-063619","document":"tv507723_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420418063619/tv507723_form4.xml","form_type":"4"}},{"id":3739311,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-12-07T21:44:10.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"70,000 shares are restricted Common Stock which vest over various time periods."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001144204-18-063619","document":"tv507723_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420418063619/tv507723_form4.xml","form_type":"4"}},{"id":3849593,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-09T01:45:28.000Z","date":"2018-08-07","kind":"gift","acquired":true,"shares":14663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 14,663 shares of restricted common stock will vest on August 7, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 64,663 shares of restricted stock."}],"balance_after":67163,"source":{"system":"sec-edgar","filing":"0001144204-18-042958","document":"tv500468_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420418042958/tv500468_form4.xml","form_type":"4"}},{"id":3892305,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-06-15T21:25:04.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":16448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 16,448 shares of restricted Common Stock will vest on June 14, 2021, subject to Mr. Herskowitz's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares of restricted Common Stock which vest over various time periods."}],"balance_after":76448,"source":{"system":"sec-edgar","filing":"0001144204-18-034457","document":"tv496608_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420418034457/tv496608_form4.xml","form_type":"4"}},{"id":3957097,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-25T20:30:48.000Z","date":"2018-04-25","kind":"purchase","acquired":true,"shares":1000,"price":3.8,"value":3800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 50,000 shares of restricted stock."}],"balance_after":52500,"source":{"system":"sec-edgar","filing":"0001144204-18-022402","document":"tv492043_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420418022402/tv492043_form4.xml","form_type":"4"}},{"id":4183636,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-18T16:19:45.000Z","date":"2017-10-17","kind":"purchase","acquired":true,"shares":1000,"price":5.01,"value":5010.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 50,000 shares of restricted stock."}],"balance_after":51500,"source":{"system":"sec-edgar","filing":"0001144204-17-052957","document":"tv477192_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420417052957/tv477192_4.xml","form_type":"4"}},{"id":4188897,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-10T12:27:49.000Z","date":"2017-10-09","kind":"purchase","acquired":true,"shares":500,"price":5.24,"value":2620.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,000 shares of restricted stock."}],"balance_after":50500,"source":{"system":"sec-edgar","filing":"0001144204-17-051782","document":"tv476706_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420417051782/tv476706_4.xml","form_type":"4"}},{"id":4280526,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2017-06-15T21:17:10.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 10,000 shares of restricted Common Stock will vest on June 15, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares of restricted Common Stock which vest over various time periods."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001144204-17-032762","document":"v469072_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420417032762/v469072_form4.xml","form_type":"4"}},{"id":4486404,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":32768,"kind":"person","name":"Herskowitz Neil","position":1,"cik":"0001298246","reported_name":"Herskowitz Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK (RESTRICTED)","published_at":"2017-01-19T21:35:11.000Z","date":"2017-01-13","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock vest as follows: One-third on January 13, 2020, one-third on January 13, 2021 and one-third on January 13, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares of restricted stock vest as follows: One-third on January 13, 2020, one-third on January 13, 2021 and one-third on January 13, 2022."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001144204-17-002930","document":"v457182_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1298246/000114420417002930/v457182_form4.xml","form_type":"4"}}]}